Literature DB >> 22340583

Three down and one to go: modeling medulloblastoma subgroups.

Charles G Eberhart1.   

Abstract

In this issue of Cancer Cell, Pei et al. and Kawauchi et al. describe murine models of an aggressive medulloblastoma subtype driven by Myc. These tumors have a cellular origin, microscopic appearance, and molecular profile distinct from those of three other major subgroups. Thus, the models fill a significant clinical need. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID: 22340583      PMCID: PMC4860738          DOI: 10.1016/j.ccr.2012.01.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  9 in total

1.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

Authors:  Yoon-Jae Cho; Aviad Tsherniak; Pablo Tamayo; Sandro Santagata; Azra Ligon; Heidi Greulich; Rameen Berhoukim; Vladimir Amani; Liliana Goumnerova; Charles G Eberhart; Ching C Lau; James M Olson; Richard J Gilbertson; Amar Gajjar; Olivier Delattre; Marcel Kool; Keith Ligon; Matthew Meyerson; Jill P Mesirov; Scott L Pomeroy
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

2.  Pleiotropic role for MYCN in medulloblastoma.

Authors:  Fredrik J Swartling; Matthew R Grimmer; Christopher S Hackett; Paul A Northcott; Qi-Wen Fan; David D Goldenberg; Jasmine Lau; Selma Masic; Kim Nguyen; Slava Yakovenko; Xiao-Ning Zhe; Heather C Flynn Gilmer; Rodney Collins; Mai Nagaoka; Joanna J Phillips; Robert B Jenkins; Tarik Tihan; Scott R Vandenberg; C David James; Kohichi Tanaka; Michael D Taylor; William A Weiss; Louis Chesler
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

3.  An animal model of MYC-driven medulloblastoma.

Authors:  Yanxin Pei; Colin E Moore; Jun Wang; Alok K Tewari; Alexey Eroshkin; Yoon-Jae Cho; Hendrik Witt; Andrey Korshunov; Tracy-Ann Read; Julia L Sun; Earlene M Schmitt; C Ryan Miller; Anne F Buckley; Roger E McLendon; Thomas F Westbrook; Paul A Northcott; Michael D Taylor; Stefan M Pfister; Phillip G Febbo; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

4.  A mouse model of the most aggressive subgroup of human medulloblastoma.

Authors:  Daisuke Kawauchi; Giles Robinson; Tamar Uziel; Paul Gibson; Jerold Rehg; Cuilan Gao; David Finkelstein; Chunxu Qu; Stanley Pounds; David W Ellison; Richard J Gilbertson; Martine F Roussel
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

5.  c-myc overexpression causes anaplasia in medulloblastoma.

Authors:  Duncan Stearns; Aneeka Chaudhry; Ty W Abel; Peter C Burger; Chi V Dang; Charles G Eberhart
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  Medulloblastoma comprises four distinct molecular variants.

Authors:  Paul A Northcott; Andrey Korshunov; Hendrik Witt; Thomas Hielscher; Charles G Eberhart; Stephen Mack; Eric Bouffet; Steven C Clifford; Cynthia E Hawkins; Pim French; James T Rutka; Stefan Pfister; Michael D Taylor
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

7.  Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.

Authors:  Zeng-Jie Yang; Tammy Ellis; Shirley L Markant; Tracy-Ann Read; Jessica D Kessler; Melissa Bourboulas; Ulrich Schüller; Robert Machold; Gord Fishell; David H Rowitch; Brandon J Wainwright; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

8.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

9.  Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.

Authors:  Ulrich Schüller; Vivi M Heine; Junhao Mao; Alvin T Kho; Allison K Dillon; Young-Goo Han; Emmanuelle Huillard; Tao Sun; Azra H Ligon; Ying Qian; Qiufu Ma; Arturo Alvarez-Buylla; Andrew P McMahon; David H Rowitch; Keith L Ligon
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

  9 in total
  11 in total

1.  UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.

Authors:  Evan F Garner; Laura L Stafman; Adele P Williams; Jamie M Aye; Caroline Goolsby; Venkatram R Atigadda; Blake P Moore; Li Nan; Jerry E Stewart; Anita B Hjelmeland; Gregory K Friedman; Elizabeth A Beierle
Journal:  J Neurooncol       Date:  2018-08-21       Impact factor: 4.130

2.  Salinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma.

Authors:  Shuang Zhou; Fengfei Wang; Ying Zhang; Max R Johnson; Steven Qian; Min Wu; Erxi Wu
Journal:  Austin J Pharmacol Ther       Date:  2014

Review 3.  Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.

Authors:  Amar Gajjar; Roger J Packer; N K Foreman; Kenneth Cohen; Daphne Haas-Kogan; Thomas E Merchant
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 4.  Medulloblastomics: the end of the beginning.

Authors:  Paul A Northcott; David T W Jones; Marcel Kool; Giles W Robinson; Richard J Gilbertson; Yoon-Jae Cho; Scott L Pomeroy; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

Review 5.  Molecular subgroups of medulloblastoma.

Authors:  Paul A Northcott; Adrian M Dubuc; Stefan Pfister; Michael D Taylor
Journal:  Expert Rev Neurother       Date:  2012-07       Impact factor: 4.618

6.  Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells.

Authors:  Raffaella Spina; Gessica Filocamo; Enrico Iaccino; Stefania Scicchitano; Michela Lupia; Emanuela Chiarella; Tiziana Mega; Francesca Bernaudo; Daniela Pelaggi; Maria Mesuraca; Simonetta Pazzaglia; Samantha Semenkow; Eli E Bar; Marcel Kool; Stefan Pfister; Heather M Bond; Charles G Eberhart; Christian Steinkühler; Giovanni Morrone
Journal:  Oncotarget       Date:  2013-08

7.  Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.

Authors:  Zai Ahmad; Lukasz Jasnos; Veronica Gil; Louise Howell; Albert Hallsworth; Kevin Petrie; Tomoyuki Sawado; Louis Chesler
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 8.  Signals that regulate the oncogenic fate of neural stem cells and progenitors.

Authors:  Fredrik J Swartling; Sara Bolin; Joanna J Phillips; Anders I Persson
Journal:  Exp Neurol       Date:  2013-01-31       Impact factor: 5.330

9.  A statin-regulated microRNA represses human c-Myc expression and function.

Authors:  Apana A L Takwi; Yan Li; Lindsey E Becker Buscaglia; Jingwen Zhang; Saibyasachi Choudhury; Ae Kyung Park; Mofang Liu; Ken H Young; Woong-Yang Park; Robert C G Martin; Yong Li
Journal:  EMBO Mol Med       Date:  2012-08-07       Impact factor: 12.137

10.  Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma.

Authors:  Martin Wilson; Simrandip K Gill; Lesley MacPherson; Martin English; Theodoros N Arvanitis; Andrew C Peet
Journal:  Clin Cancer Res       Date:  2014-06-19       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.